4041. Performance of an MRI scoring system for inflammation of joints and entheses in peripheral SpA: post-hoc analysis of the CRESPA trial.
作者: Simon Krabbe.;Thomas Renson.;Lennart Jans.;Dirk Elewaut.;Filip Van den Bosch.;Philippe Carron.;Mikkel Østergaard.
来源: Rheumatology (Oxford). 2023年62卷6期2130-2138页
The aim of this study was to investigate the reliability, validity, and sensitivity to change of a novel MRI scoring system in early peripheral SpA (pSpA).
4042. Revisiting idiopathic eosinophilic myositis: towards a clinical-pathological continuum from the muscle to the fascia and skin.
作者: Cécile Fermon.;Lola E R Lessard.;Tanguy Fenouil.;Alain Meyer.;Marie Faruch-Bilfeld.;Marie Robert.;Verena Landel.;Arnaud Hot.;François-Jérôme Authier.;Nathalie Streichenberger.;Laure Gallay.
来源: Rheumatology (Oxford). 2023年62卷6期2220-2229页
Idiopathic inflammatory myopathies are mainly defined by inflammatory infiltrates within the muscle (lymphocytes and macrophages). Eosinophil muscle infiltration has been described in idiopathic eosinophilic myositis (IEM) and rarely in EF. This study aimed to further delineate the nosological frame of idiopathic eosinophil muscle infiltration through the exhaustive analysis of IEM and EF patients.
4043. Monkeypox in a patient with undifferentiated connective tissue disease.
作者: Tommaso Clemente.;Diana Canetti.;Lorenzo Dagna.;Caterina Uberti Foppa.;Antonella Castagna.;Vincenzo Spagnuolo.;Silvia Nozza.;Corrado Campochiaro.
来源: Rheumatology (Oxford). 2023年62卷5期e158-e160页 4045. A new autoantibody to valyl transfer RNA synthetase associated with anti-synthetase syndrome.
作者: Tsuneo Sasai.;Ran Nakashima.;Mirei Shirakashi.;Ryosuke Hiwa.;Hideaki Tsuji.;Koji Kitagori.;Shuji Akizuki.;Hajime Yoshifuji.;Tsuneyo Mimori.;Akio Morinobu.
来源: Rheumatology (Oxford). 2023年62卷5期e155-e157页 4047. Novel mutation and expanding phenotype in IRF2BP2 deficiency.
作者: Julia Körholz.;Anastasia Gabrielyan.;Henrike Lisa Sczakiel.;Livia Schulze.;Manuela Rejzek.;Martin W Laass.;Nicolai Leuchten.;Oliver Tiebel.;Diana Aust.;Karsten Conrad.;Nadja Röber.;Eva-Maria Jacobsen.;Nadja Ehmke.;Reinhard Berner.;Nadja Lucas.;Minae A Lee-Kirsch.;Ralf Wiedemuth.;Joachim Roesler.;Axel Roers.;Timm Amendt.;Catharina Schuetz.
来源: Rheumatology (Oxford). 2023年62卷4期1699-1705页
Inborn errors of immunity manifest with susceptibility to infection but may also present with immune dysregulation only. According to the European Society for Immunodeficiencies Registry about 50% of inborn errors of immunity are classified as common variable immunodeficiencies (CVID). In only few CVID patients are monogenic causes identified. IFN regulatory factor-2 binding protein 2 (IRF2BP2) is one of 20 known genes associated with CVID phenotypes and has only been reported in two families so far. We report another IRF2BP2-deficient patient with a novel pathogenic variant and phenotype and characterize impaired B cell function and immune dysregulation.
4048. Comparison of health-care utilization, costs and health-related quality of life across the subgroups defined by the Keele STarT MSK Tool.
作者: Raymond Oppong.;Martyn Lewis.;Paul Campbell.;Kate M Dunn.;Nadine E Foster.;Jonathan C Hill.;Sue Jowett.
来源: Rheumatology (Oxford). 2023年62卷6期2076-2082页
The aim of this study was to describe and compare health economic outcomes [health-care utilization and costs, work outcomes, and health-related quality of life (EQ-5D-5L)] in patients classified into different levels-of-risk subgroups by the Keele STarT MSK Tool.
4049. Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases.
作者: Yann Nguyen.;Cécile M Yelnik.;Nathalie Morel.;Romain Paule.;Romain Stammler.;Léo Plaçais.;Karim Sacré.;Bertrand Godeau.;Hélène Maillard.;David Launay.;Sandrine Morell-Dubois.;Anastasia Dupré.;Guillaume Lefèvre.;Cécile Devloo.;Virginie Dufrost.;Ygal Benhamou.;Hervé Levesque.;Gaëlle Leroux.;Jean-Charles Piette.;Luc Mouthon.;Éric Hachulla.;Marc Lambert.;Véronique Le Guern.;Nathalie Costedoat-Chalumeau.
来源: Rheumatology (Oxford). 2023年62卷8期2813-2819页
APS is a heterogeneous disease with different phenotypes. Using an unsupervised hierarchical cluster analysis, we aimed to determine distinct homogeneous phenotypes among APS patients.
4050. Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study.
作者: Alessandro Giollo.;Margherita Zen.;Maddalena Larosa.;Davide Astorri.;Mariangela Salvato.;Antonia Calligaro.;Konstantinos Botsios.;Cristina Bernardi.;Gerolamo Bianchi.;Andrea Doria.
来源: Rheumatology (Oxford). 2023年62卷6期2083-2089页
To demonstrate that unsuccessful treatment optimization in early disease is associated with difficult-to-treat RA (D2T-RA).
4051. Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis.
作者: Ryan M Hum.;Pauline Ho.;Nisha Nair.;Meghna Jani.;Ann W Morgan.;John D Isaacs.;Anthony G Wilson.;Kimme L Hyrich.;Darren Plant.;Anne Barton.; .
来源: Rheumatology (Oxford). 2023年62卷6期2090-2097页
Interventions aimed at increasing TNF-α inhibitor serum drug levels (SDLs) may improve treatment response; however, previous studies suggesting SDL cut-offs have not accounted for treatment adherence. The aim of this study was to establish the relationship between adalimumab/certolizumab SDLs and EULAR good vs non-/moderate response and to define SDL cut-offs associated with good response in fully adherent patients.
4052. Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study.
作者: Paul Breillat.;Marie Jachiet.;Yoan Ditchi.;Cédric Lenormand.;Nathalie Costedoat-Chalumeau.;Alexis Mathian.;Philippe Moguelet.;Paul Duriez.;Marten Trendelenburg.;Uyen Huynh-Do.;Carlo Chizzolini.;Clément Beuvon.;Frederique Roy-Peaud.;Jean-David Bouaziz.;Annick Barbaud.;Camille Francès.;Arsène Mékinian.;Olivier Fain.;Zahir Amoura.;François Chasset.; .
来源: Rheumatology (Oxford). 2023年62卷6期2189-2196页
To describe the clinical and pathological features of biopsy-proven cutaneous vasculitis (CV) associated with SLE, focusing on diagnosis classification and impact on overall SLE activity.
4053. Trust in the attending rheumatologist, health-related hope and medication adherence among Japanese systemic lupus erythematosus patients.
作者: Noriaki Kurita.;Nao Oguro.;Yoshia Miyawaki.;Chiharu Hidekawa.;Natsuki Sakurai.;Takanori Ichikawa.;Yuichi Ishikawa.;Keigo Hayashi.;Kenta Shidahara.;Dai Kishida.;Ryusuke Yoshimi.;Ken-Ei Sada.;Yasuhiro Shimojima.;Nobuyuki Yajima.
来源: Rheumatology (Oxford). 2023年62卷6期2147-2153页
Poor medication adherence among patients with SLE is a critical problem associated with adverse outcomes. This study examined the relationship between trust in one's physician and goal-oriented thinking, hope and medication adherence among Japanese patients with SLE who were ethnically matched to their physicians.
4054. Type H vessels-a bridge connecting subchondral bone remodelling and articular cartilage degeneration in osteoarthritis development.
Recent studies have shed light on the cellular and molecular mechanisms that link subchondral bone remodelling and angiogenesis in knee osteoarthritis (OA). Type H vessels are a newly identified bone blood vessel characterized by high expression of CD31 and endomucin that are coupled with osteogenesis. Factors including mechanical loading, TGF-β1, platelet-derived growth factor type BB, the osteoprotegerin-RANK ligand-RANK system, osteopontin, mechanistic target of rapamycin, VEGF, stromal cell-derived factor l and prostaglandin E2 participate in the formation of type H vessels in osteoarthritic subchondral bone. In this review, we summarize the current understanding of type H vessels in knee OA, as well as the signalling pathways involved and potential therapeutic medicines. In future, the pathogenesis of knee OA could be further clarified by connecting type H vessels and the design of new disease-modifying osteoarthritis drugs. However, further experiments are needed to determine the upstream signals regulating type H vessel formation in osteoarthritic subchondral bone.
4055. Baseline knee extension may be associated with volumetric cartilage loss in the anterolateral tibia: data from the Osteoarthritis Initiative.
作者: T Mark Campbell.;Katherine Reilly.;Odette Laneuville.;Hans K Uhthoff.;Guy Trudel.
来源: Rheumatology (Oxford). 2023年62卷5期1950-1954页
Animal studies suggest regional unloading of the knee due to flexion contracture (FC) results in cartilage loss in the anterior tibia. We looked for an association between the range of knee extension and articular cartilage thickness in the tibia of patients with knee OA, using quantitative MRI data from the OA Initiative.
4056. Association between beverage consumption and risk of rheumatoid arthritis: a prospective study from the French E3N Cohort.
作者: Sophia Ascione.;François Barde.;Fanny Artaud.;Yann Nguyen.;Conor Macdonald.;Xavier Mariette.;Marie-Christine Boutron-Ruault.;Carine Salliot.;Raphaèle Seror.
来源: Rheumatology (Oxford). 2023年62卷5期1814-1823页
To assess the relationship between consumption of largely consumed beverages (coffee, tea, alcohol and soft drinks) and the risk of RA.
4057. Smartphone images of digital ulcers provide a clear picture of disease progression for the first rheumatology visit.
作者: Anastasia-Vasiliki Madenidou.;Graham Dinsdale.;Muditha Samaranayaka.;Lindsay Muir.;William G Dixon.;Ariane L Herrick.
来源: Rheumatology (Oxford). 2023年62卷5期e153-e154页 4058. Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.
作者: David Roofeh.;Kevin K Brown.;Ella A Kazerooni.;Donald Tashkin.;Shervin Assassi.;Fernando Martinez.;Athol U Wells.;Ganesh Raghu.;Christopher P Denton.;Lorinda Chung.;Anna-Maria Hoffmann-Vold.;Oliver Distler.;Kerri A Johannson.;Yannick Allanore.;Eric L Matteson.;Leticia Kawano-Dourado.;John D Pauling.;James R Seibold.;Elizabeth R Volkmann.;Simon L F Walsh.;Chester V Oddis.;Eric S White.;Shaney L Barratt.;Elana J Bernstein.;Robyn T Domsic.;Paul F Dellaripa.;Richard Conway.;Ivan Rosas.;Nitin Bhatt.;Vivien Hsu.;Francesca Ingegnoli.;Bashar Kahaleh.;Puneet Garcha.;Nishant Gupta.;Surabhi Khanna.;Peter Korsten.;Celia Lin.;Stephen C Mathai.;Vibeke Strand.;Tracy J Doyle.;Virginia Steen.;Donald F Zoz.;Juan Ovalles-Bonilla.;Ignasi Rodriguez-Pinto.;Padmanabha D Shenoy.;Andrew Lewandoski.;Elizabeth Belloli.;Alain Lescoat.;Vivek Nagaraja.;Wen Ye.;Suiyuan Huang.;Toby Maher.;Dinesh Khanna.
来源: Rheumatology (Oxford). 2023年62卷5期1877-1886页
To establish a framework by which experts define disease subsets in systemic sclerosis associated interstitial lung disease (SSc-ILD).
4059. Improved sensitivity of the skin pathergy test with polysaccharide pneumococcal vaccine antigens in the diagnosis of Behçet disease.
作者: Rabia Deniz.;Zeliha Emrence.;Yasemin Yalçınkaya.;Bahar Artım Esen.;Murat İnanç.;Mahdume Lale Öcal.;Ahmet Gül.
来源: Rheumatology (Oxford). 2023年62卷5期1903-1909页
The skin pathergy test (SPT) is an important tool in the diagnosis of Behçet disease (BD), but its decreasing sensitivity over years has resulted in less frequent use in the clinical practice. This study aimed to improve the sensitivity of the SPT without compromising its specificity.
4060. A novel long non-coding RNA, lnc-RNU12, influences the T-cell cycle via c-JUN and CCNL2 in rheumatoid arthritis.
作者: Xing-Bo Mo.;Yang-Hua Sun.;Long-Fei Wu.;Pei He.;Rong-Rong Cao.;Xin Lu.;Yong-Hong Zhang.;Fei-Yan Deng.;Shu-Feng Lei.
来源: Rheumatology (Oxford). 2023年62卷5期1955-1963页
Long non-coding RNAs (lncRNAs) play important roles in RA pathogenesis. However, specific lncRNAs that regulate gene expression in RA pathogenesis are poorly known. This study was undertaken to characterize a novel lncRNA (lnc-RNU12) that has a lower-than-normal expression level in RA patients.
|